Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: sim1 who wrote (15965)	3/4/2005 1:59:53 AM
From: zeta1961	Read Replies (1) \| Respond to of 52153

nationalmssociety.org Did anyone here know that Rituxan is being studied in primary progressive MS? BIIB is for me, is turning into the equivalent one of those wines with a good 'nose' but black pepper spray taste! Thanks all for keeping this thread up to the minute current..edit: oops, thought I was on ELN..but thanks here too! Also..does anyone have access to Science from last summer in which Steinman of Stanford apparently wrote about caution for Tysabri? Thanks and best of luck all, Zeta